Trial Profile
A Phase I Clinical Trial of Capecitabine and SIR-Spheres® Y-90-Radioembolization in Patients With Advanced Intrahepatic Cholangiocarcinoma
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Yttrium-90 (Primary)
- Indications Adenocarcinoma; Cholangiocarcinoma
- Focus Adverse reactions
- 21 Apr 2017 New trial record